LEADER 01782nam0 2200349 i 450 001 SUN0054866 005 20180601092354.681 010 $a978-05-213-5949-8$d0.00 100 $a20061025d1990 |0engc50 ba 101 $aeng 102 $aGB 105 $a|||| ||||| 200 1 $aThe *subgroup structure of the finite classical groups$fPeter Kleidman, Martin Liebeck 210 $aCambridge$cCambridge University$d1990 215 $aVII, 303 p.$d24 cm. 410 1$1001SUN0029528$12001 $a*London Mathematical Society lecture notes series$v129$1210 $aCambridge$cCambridge university. 606 $a20-XX$xGroup theory and generalizations [MSC 2020]$2MF$3SUNC019715 606 $a20D06$xSimple groups: alternating groups and groups of Lie type [MSC 2020]$2MF$3SUNC023834 606 $a20G40$xLinear algebraic groups over finite fields [MSC 2020]$2MF$3SUNC023977 606 $a20D30$xSeries and lattices of subgroups [MSC 2020]$2MF$3SUNC023983 606 $a20E28$xMaximal subgroups [MSC 2020]$2MF$3SUNC024101 620 $dCambridge$3SUNL000024 700 1$aKleidman$b, Peter$3SUNV043372$0440846 702 1$aLiebeck$b, Martin$3SUNV042807 712 $aCambridge university$3SUNV000097$4650 790 1$aLiebeck, M. W.$zLiebeck, Martin$3SUNV042808 801 $aIT$bSOL$c20200727$gRICA 856 4 $uhttps://books.google.it/books?id=PbSKxFnkuMsC&printsec=frontcover&dq=9780521359498&hl=it&sa=X&ved=0ahUKEwj807Wn97HbAhUObVAKHZ97BBIQ6AEIJzAA#v=onepage&q&f=false$zPreview 912 $aSUN0054866 950 $aUFFICIO DI BIBLIOTECA DEL DIPARTIMENTO DI MATEMATICA E FISICA$d08PREST 20-XX 2205 $e08 1900 I 20061108 996 $aSubgroup structure of the finite classical groups$9918962 997 $aUNICAMPANIA LEADER 05004nam 22006015 450 001 9910494558003321 005 20251113202602.0 010 $a981-336-850-0 024 7 $a10.1007/978-981-33-6850-7 035 $a(CKB)4100000011994644 035 $a(MiAaPQ)EBC6688960 035 $a(Au-PeEL)EBL6688960 035 $a(PPN)260306436 035 $a(OCoLC)1262554045 035 $a(DE-He213)978-981-33-6850-7 035 $a(EXLCZ)994100000011994644 100 $a20210730d2021 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aMedicinal Plants for Lung Diseases $eA Pharmacological and Immunological Perspective /$fedited by Kamal Dua, Srinivas Nammi, Dennis Chang, Dinesh Kumar Chellappan, Gaurav Gupta, Trudi Collet 205 $a1st ed. 2021. 210 1$aSingapore :$cSpringer Nature Singapore :$cImprint: Springer,$d2021. 215 $a1 online resource (625 pages) 225 1 $aBiomedical and Life Sciences Series 311 08$a981-336-849-7 320 $aIncludes bibliographical references. 327 $aChapter 1. Immunopathology of respiratory diseases -- Chapter 2. Introduction to Chronic Respiratory Diseases: A Pressing Need for Novel Therapeutic Approaches -- Chapter 3. Role of Indian Herbal Medicine in the treatment of Pulmonary Diseases -- Chapter 4. Asthma-induced inflammatory responses and reversal by botanicals -- Chapter 5. Medicinal plants in targeting asthma -- Chapter 6. Incipient need of medicinal plants in targeting chronic obstructive pulmonary disease -- Chapter 7. Utilization of Natural Compounds for Treatment of Tuberculosis-I -- Chapter 8. Medicinal plants in the treatment of Tuberculosis-II -- Chapter 9. Medicinal Plants in the Treatment of tuberculosis-III -- Chapter 10.Natural compounds as versatile potential therapeutic agents of lung cancer -- Chapter 11. Exploring the potential of medicinal plants in Lung Cancer -- Chapter 12. Effect of Medicinal Plants against Lung Cancer -- Chapter 13. Medicinal Plants used in the treatment of pulmonary hypertension- I -- Chapter 14.Medicinal Plants used in the treatment of pulmonary hypertension-II -- Chapter 15. Herbal bioactives for the treatment of idiopathic pulmonary fibrosis -- Chapter 16. Medicinal Plants targeting Bronchitis -- Chapter 17. Role of medicinal plants in the treatment of pulmonary edema -- Chapter 18. Medicinal Plants Used in the Treatment of Influenza a Virus Infections -- Chapter 19. Medicinal Plants used in the treatment of influenza A virus infections -- Chapter 20. COVID-19 pandemic panic: prophylactic as well as therapeutic management with traditional ethnic phytopharmaceuticals with challenging nano-spray inhaler and advanced drug delivery system -- Chapter 21. Targeting SARS-CoV2 novel corona (COVID-19) virus infection using medicinal plants -- Chapter 22. Promising plant based bioactive natural products in combating SARS-CoV2 novel corona (COVID-19) virus infection -- Chapter 23. Medicinal plant based advanced drug delivery system for the treatment of chronic lung diseases -- Chapter 24. Medicinal Plant Based Advanced Drug Delivery System for the Treatment of Chronic Lung Diseases -- Chapter 25. Application of nanodrugs derived from active metabolites of medicinal plants for the treatment of inflammatory and lung diseases: Recent advances. 330 $aThis book summarizes experimentally-supported research on the therapeutic efficacy of plant extracts and their constituents on a range of respiratory diseases including infections. It discusses the pharmacological, cellular and molecular factors involved in the pathogenies of respiratory diseases and their modulation by plant-derived compounds. Additionally, it underlines the growing relevance of medicinal plant-based advanced drug delivery systems for treating lung diseases providing maximal therapeutic efficacy with better patient compliance. Overall, this comprehensive book is a blend of translational, biological, chemical and drug delivery aspects of medicinal plants employed in targeting respiratory diseases and attracts a range of audiences including physiochemist, translational and clinical researchers working in the field of respiratory diseases. 410 0$aBiomedical and Life Sciences Series 606 $aHuman physiology 606 $aPharmaceutical chemistry 606 $aDrug delivery systems 606 $aHuman Physiology 606 $aPharmaceutics 606 $aDrug Delivery 615 0$aHuman physiology. 615 0$aPharmaceutical chemistry. 615 0$aDrug delivery systems. 615 14$aHuman Physiology. 615 24$aPharmaceutics. 615 24$aDrug Delivery. 676 $a616.248 702 $aDua$b Kamal 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910494558003321 996 $aMedicinal plants for lung diseases$92834348 997 $aUNINA